EDI vs. API in Pharma: When You Need One, the Other, or Both

If you're evaluating connectivity options for your pharma operation, you've probably run into the EDI vs. API question. The framing can make it sound like a binary choice — as if you need to pick a side. In practice, most pharma operations use both, just for different purposes.

This article is written for IT and operations leaders who need to make practical decisions about trading-partner connectivity and internal system integrations. The goal isn't to advocate for one approach over the other — it's to help you understand what each tool is actually designed to do, and where the real problems tend to surface when teams try to use the wrong one.

---

What EDI and APIs Actually Are

EDI: Standardized document exchange between trading partners

EDI — electronic data interchange — is a set of standardized message formats used to exchange business documents between organizations. In pharma supply chains, the most common documents are purchase orders (EDI 850), invoices (EDI 810), and advance ship notices (EDI 856). If you've worked with wholesalers, distributors, manufacturers, or GPOs, you've almost certainly encountered EDI, whether or not you managed it directly.

The key word is standardized. EDI works because both sides agree on the format before the first document is sent. That standardization is what makes it the established protocol for partner-to-partner document flow. (For a deeper look at how these documents work in practice, see our guide to EDI 850, 810, and 856 explained.)

APIs: Flexible system-to-system integrations

APIs — application programming interfaces — let software systems talk to each other in real time. Unlike EDI, which follows fixed message formats, APIs are flexible: the data structure, timing, and logic can be designed around the specific systems being connected.

APIs are the standard approach for connecting internal applications — your ERP, warehouse management system (WMS), or pharmacy management software. They're also how most modern SaaS platforms expose their data to other tools.

---

Why the Distinction Matters in Pharma

Pharma supply chains involve two distinct categories of integration:

• External, partner-to-partner document exchange — purchase orders, invoices, ASNs flowing between your organization and trading partners like wholesalers, distributors, manufacturers, or buying groups
• Internal, system-to-system data flow — order data moving from your pharmacy management platform into your ERP, inventory updates syncing to your WMS, or reporting data flowing to a BI tool

These are different problems, and they're typically solved by different tools.

Trading partners — especially large wholesalers and distributors — generally require EDI for core document workflows. That's not a preference; it's often a technical requirement. If a trading partner's system expects an EDI 850, sending them a REST API call won't work. EDI is the lingua franca of pharma supply-chain documents, and it's been that way for decades.

Internal systems, on the other hand, usually integrate via API or file-based exchange. Most modern ERP and pharmacy management platforms are built to connect via API. Real-time visibility into inventory, order status, or fulfillment often depends on API connectivity — EDI's batch-oriented nature typically isn't the right fit for that kind of internal data flow.

If you're newer to how EDI works in pharma more broadly, our intro to pharma EDI covers the fundamentals.

---

Common Challenges When Teams Force the Wrong Tool

The most avoidable problems we see tend to come from trying to make one technology do the other's job.

Custom APIs against trading partners that only support EDI. Some teams, preferring APIs, attempt to build custom integrations against wholesalers or distributors that have no API channel. This usually results in significant development time spent building workarounds — file parsing, scheduled jobs, fragile connections — when the trading partner's actual supported channel is EDI.

EDI mappings for internal workflows that should be APIs. The opposite also happens: teams that are comfortable with EDI sometimes try to use it for internal integrations where APIs would be simpler, faster, and easier to maintain. EDI's overhead — mapping, testing, acknowledgment handling — isn't justified when you control both ends of the connection.

Managing two separate vendor relationships without coordination. Organizations that handle external EDI with one vendor and internal API integrations with another often find that the handoff between the two creates its own operational friction — especially when troubleshooting a transaction that crosses both.

---

How to Think About Which to Use

A practical framework:

Use EDI when:

• A trading partner requires it (this is usually non-negotiable)
• The documents being exchanged are standardized — purchase orders, invoices, ASNs
• The relationship is partner-to-partner, not system-to-system within your own environment
• You need a documented, acknowledgment-based audit trail for compliance purposes

Use APIs when:

• You control both ends of the integration
• Real-time data updates matter — inventory availability, order status, fulfillment confirmation
• The data structure is flexible or proprietary to your internal systems
• You're connecting modern SaaS platforms that expose API endpoints

Use both when:

• Your operations involve trading partners and internal system integrations — which describes most pharma operators of any meaningful scale
• You're receiving EDI documents from a trading partner that need to flow into an ERP or WMS via API
• You want to avoid duplicating operational work across two separate integration layers

---

How Managed EDI Can Help

One option worth considering: working with a managed EDI provider that also supports API connectivity. That kind of service can handle both the external trading-partner side (standard EDI mapping, testing, monitoring, and support) and the internal side (API connections to your ERP or pharmacy system).

The practical advantage is consolidation. Rather than coordinating between two vendors when a transaction fails — or debugging where a document got lost between your EDI layer and your internal system — you're working with one team that can see the full picture.

A managed approach also reduces the in-house expertise required. EDI mapping is technical work, and partner onboarding can involve multiple test cycles and back-and-forth with the partner's EDI team. Offloading that to a managed service — while maintaining API flexibility for internal systems — often reduces time-to-live and ongoing maintenance burden.

---

Where APXConnect Fits

APXConnect is a managed EDI and API service built specifically for pharma trading-partner workflows. It's designed for teams that want reliable trading-partner connectivity without taking on the full operational overhead of managing maps, test cycles, and support issues internally.

The typical starting point: customers send APXConnect their trading partner list, document requirements, and current setup. APXConnect helps manage mapping, testing, monitoring, and ongoing support. Trading partners with existing maps can often go live in days; new partner maps typically take one to three weeks, depending on partner responsiveness and workflow complexity.

Pricing is flat monthly — no per-transaction fees — across three tiers depending on how many trading partners you're managing. You can review the pricing plans if you want a sense of where your operation might land.

---

Frequently Asked Questions

Can a trading partner use both EDI and API?

Some trading partners offer API channels in addition to EDI, but this varies significantly by partner. Many large wholesalers and distributors have EDI as their primary or only supported channel for standard supply-chain documents. It's worth confirming with each partner what they actually support before committing to an integration approach.

Is EDI being replaced by APIs in pharma?

Not in any near-term, wholesale way. APIs are increasingly common for specific use cases — particularly where real-time data matters or where both parties are technology-forward — but EDI remains the dominant standard for core pharma supply-chain documents. Most pharma operations are managing both, not replacing one with the other.

What's the difference between EDI 850, 810, and 856?

These are three of the most common EDI transaction sets in pharma: the 850 is a purchase order, the 810 is an invoice, and the 856 is an advance ship notice. Our article on EDI 850, 810, and 856 explained walks through how each one works and where it fits in the order cycle.

Do I need technical staff to manage EDI and API integrations?

With a self-managed EDI solution, yes — you typically need someone with EDI mapping and VAN experience. With a managed service, that expertise is handled by the provider. API integrations vary: connecting modern platforms often involves some technical setup, but managed services can often support that layer as well, reducing the in-house burden.

How long does it take to go live with a new trading partner?

It depends on whether the partner's map already exists and how quickly the partner's EDI team responds during testing. For partners with existing maps, go-live can often happen in days. For net-new maps, one to three weeks is a typical range — though partner responsiveness is often the primary variable.

---

Next Steps

If you're sorting through your trading partner list and trying to figure out where EDI ends and your API layer begins, it helps to talk through the specifics. Share your setup — partners, document types, internal systems — and we can help map the fastest path to a working integration.

Talk through my EDI setup →